Recently, Dos Santos et al. [67] investigated the relationship among KRAS, AURKA, and AURKB in lung cancer cells and evaluated the role of inhibition of Aurora kinases can lead to real therapeutic benefit. This evidence concerns the gene KRAS and lung cancer.